1. Home
  2. MDXG vs OPK Comparison

MDXG vs OPK Comparison

Compare MDXG & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • OPK
  • Stock Information
  • Founded
  • MDXG 2006
  • OPK 2007
  • Country
  • MDXG United States
  • OPK United States
  • Employees
  • MDXG N/A
  • OPK N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • OPK Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDXG Health Care
  • OPK Health Care
  • Exchange
  • MDXG Nasdaq
  • OPK Nasdaq
  • Market Cap
  • MDXG 999.9M
  • OPK N/A
  • IPO Year
  • MDXG N/A
  • OPK 1995
  • Fundamental
  • Price
  • MDXG $6.14
  • OPK $1.32
  • Analyst Decision
  • MDXG Strong Buy
  • OPK Buy
  • Analyst Count
  • MDXG 2
  • OPK 4
  • Target Price
  • MDXG $12.50
  • OPK $2.75
  • AVG Volume (30 Days)
  • MDXG 594.7K
  • OPK 3.6M
  • Earning Date
  • MDXG 07-30-2025
  • OPK 08-06-2025
  • Dividend Yield
  • MDXG N/A
  • OPK N/A
  • EPS Growth
  • MDXG N/A
  • OPK N/A
  • EPS
  • MDXG 0.27
  • OPK N/A
  • Revenue
  • MDXG $352,375,000.00
  • OPK $689,408,000.00
  • Revenue This Year
  • MDXG $9.55
  • OPK N/A
  • Revenue Next Year
  • MDXG $11.43
  • OPK $7.80
  • P/E Ratio
  • MDXG $22.56
  • OPK N/A
  • Revenue Growth
  • MDXG 5.34
  • OPK N/A
  • 52 Week Low
  • MDXG $5.47
  • OPK $1.19
  • 52 Week High
  • MDXG $10.14
  • OPK $2.04
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 35.28
  • OPK 48.65
  • Support Level
  • MDXG $5.79
  • OPK $1.26
  • Resistance Level
  • MDXG $6.05
  • OPK $1.37
  • Average True Range (ATR)
  • MDXG 0.19
  • OPK 0.04
  • MACD
  • MDXG 0.00
  • OPK 0.00
  • Stochastic Oscillator
  • MDXG 14.81
  • OPK 53.33

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: